Ad
related to: regn stock news today- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- 2024's Gold Rush is Here
Gold Prices Could Reach New Highs
See This Year's Top Gold Plays Free
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Anti-Gold Investor Guide
Search results
Results from the WOW.Com Content Network
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Regeneron (REGN) closed at $594.90 in the latest trading session, marking a -0.28% move from the prior day.
Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) started 2024 on a strong note and performed well through the first half of the year. Regeneron's stock could soar by 50% in the next year ...
Would a stock split help lead Regeneron Pharmaceuticals shares higher?
Yahoo Finance Live examines Regeneron Pharmaceuticals' stock following reports of positive results in its eye treatment drug trials.
On Friday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion recommending ...
Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.
For premium support please call: 800-290-4726 more ways to reach us
Ad
related to: regn stock news today